Gurrola Sandra M Insider Trades

Insider Trading History

Track insider trading activity for Gurrola Sandra M. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Eterna Therapeutics
Eterna Therapeutics ERNA
Sr. VP Of Finance
Holding Value $901 110 shares
Last Trade
Jun 21, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$73.5 30 shares
$2.45
$8.19
Eterna Therapeutics
Eterna Therapeutics ERNA
Sr. VP Of Finance
Holding Value $1.23M 150,000 shares
Last Trade
Feb 07, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$756k 150,000 shares
$5.04
$8.19
Eterna Therapeutics
Eterna Therapeutics ERNA
Sr. VP Of Finance
Holding Value $11.2k 1,365 shares
Last Trade
Jun 21, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$12.7k 437 shares
$29.10
$8.19
Eterna Therapeutics
Eterna Therapeutics ERNA
Sr. VP Of Finance
Holding Value $3.58k 437 shares
Last Trade
Jun 21, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$12.7k 437 shares
$29.10
$8.19
Eterna Therapeutics
Eterna Therapeutics ERNA
Sr. VP Of Finance
Holding Value $9.71k 1,185 shares
Last Trade
Jun 21, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$5.24k 180 shares
$29.10
$8.19
Eterna Therapeutics
Eterna Therapeutics ERNA
Sr. VP Of Finance
Holding Value $655k 80,000 shares
Last Trade
Apr 26, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.15M 80,000 shares
$26.85
$8.19
Brooklyn ImmunoTherapeutics
Brooklyn ImmunoTherapeutics BTX
Vice President Of Finance
Holding Value $10.2k 1,107 shares
Last Trade
Jun 21, 2023 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$89.8 438 shares
$0.21
$9.21
Eterna Therapeutics
Eterna Therapeutics ERNA
Vice President Of Finance
Holding Value $7.6k 928 shares
Last Trade
Jun 21, 2023 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$6.66k 179 shares
$37.20
$8.19
Eterna Therapeutics
Eterna Therapeutics ERNA
Vice President Of Finance
Holding Value $7.16k 874 shares
Last Trade
Jun 21, 2023 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$16.3k 438 shares
$37.20
$8.19
Eterna Therapeutics
Eterna Therapeutics ERNA
Vice President Of Finance
Holding Value $9.07k 1,107 shares
Last Trade
Jun 21, 2023 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$16.3k 438 shares
$37.20
$8.19
Brooklyn ImmunoTherapeutics
Brooklyn ImmunoTherapeutics BTX
Vice President Of Finance
Holding Value $8.05k 874 shares
Last Trade
Jun 21, 2023 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$89.8 438 shares
$0.21
$9.21
Brooklyn ImmunoTherapeutics
Brooklyn ImmunoTherapeutics BTX
Vice President Of Finance
Holding Value $8.55k 928 shares
Last Trade
Jun 21, 2023 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$36.7 179 shares
$0.21
$9.21
Eterna Therapeutics
Eterna Therapeutics ERNA
Director, Vice President Of Finance
Holding Value $215k 26,250 shares
Last Trade
Jun 21, 2022 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$2.52M 17,500 shares
$144.00
$8.19
Eterna Therapeutics
Eterna Therapeutics ERNA
Director, Vice President Of Finance
Holding Value $109k 13,367 shares
Last Trade
Jun 21, 2022 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$1.03M 7,172 shares
$144.00
$8.19
Eterna Therapeutics
Eterna Therapeutics ERNA
Vice President Of Finance
Holding Value $139k 16,953 shares
Last Trade
Jun 21, 2022 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.26M 8,750 shares
$144.00
$8.19
Eterna Therapeutics
Eterna Therapeutics ERNA
Vice President Of Finance
Holding Value $938k 114,500 shares
Last Trade
Mar 11, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$133M 229,000 shares
$579.00
$8.19
Eterna Therapeutics
Eterna Therapeutics ERNA
Director, Vice President Of Finance
Holding Value $938k 114,500 shares
Last Trade
Mar 11, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$66.3M 114,500 shares
$579.00
$8.19
Eterna Therapeutics
Eterna Therapeutics ERNA
Vice President Of Finance
Holding Value $287k 35,000 shares
Last Trade
Jun 21, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$338M 70,000 shares
$4,830.00
$8.19
NTN Buzztime
NTN Buzztime NTN
SVP Of Finance
Holding Value $58.4k 21,617 shares
Last Trade
Mar 24, 2021 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$16.3k 6,094 shares
$2.67
$2.70
Eterna Therapeutics
Eterna Therapeutics ERNA
Former SVP Of Finance
Holding Value $177k 21,617 shares
Last Trade
Mar 24, 2021 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$19.5M 12,188 shares
$1,602.00
$8.19

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up